|
|
||||||||
American Journal of Roentgenology, Vol 169, 1671-1674, Copyright © 1997 by American Roentgen Ray Society
ARTICLES |
DR Neumann, CB Esselstyn Jr, RT Go, CO Wong, TW Rice and NA Obuchowski
Department of Nuclear Medicine, Cleveland Clinic Foundation, OH 44195, USA.
OBJECTIVE: Our purpose was to compare double-phase 99mTc-sestamibi single-photon emission computed tomography (SPECT) and simultaneous 123I-99mTc-sestamibi subtraction SPECT for preoperative localization of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism. SUBJECTS AND METHODS: Fifteen patients with primary hyperparathyroidism underwent preoperative double-phase 99mTc- sestamibi SPECT and simultaneous 123I-99mTc-sestamibi subtraction SPECT imaging. At surgery, the location, weight, and histopathologic evaluation of all identified parathyroid glands were recorded. RESULTS: At surgery, 17 parathyroid adenomas and 37 normal parathyroid glands were identified. The sensitivity, specificity, and diagnostic accuracy for the detection of parathyroid adenomas were 88%, 97%, and 94%, respectively, for simultaneous 123I-99mTc-sestamibi subtraction SPECT and 53%, 86%, and 76%, respectively, for double-phase 99mTc-sestamibi SPECT. The differences in sensitivity and diagnostic accuracy were statistically significant (p = .031 and p = .016, respectively). CONCLUSION: Compared with double-phase 99mTc-sestamibi SPECT, simultaneous 123I-99mTc-sestamibi subtraction SPECT is a superior imaging study for the preoperative localization of hyperfunctioning parathyroid tissue.
This article has been cited by other articles:
![]() |
D. R. Neumann, N. A. Obuchowski, and F. P. DiFilippo Preoperative 123I/99mTc-Sestamibi Subtraction SPECT and SPECT/CT in Primary Hyperparathyroidism J. Nucl. Med., December 1, 2008; 49(12): 2012 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Eslamy and H. A. Ziessman Parathyroid Scintigraphy in Patients with Primary Hyperparathyroidism: 99mTc Sestamibi SPECT and SPECT/CT RadioGraphics, September 1, 2008; 28(5): 1461 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ruda, B. C. Stack Jr, and C. S. Hollenbeak The Cost-effectiveness of Additional Preoperative Ultrasonography or Sestamibi-SPECT in Patients With Primary Hyperparathyroidism and Negative Findings on Sestamibi Scans Arch Otolaryngol Head Neck Surg, January 1, 2006; 132(1): 46 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mariani, S. A. Gulec, D. Rubello, G. Boni, M. Puccini, M. R. Pelizzo, G. Manca, D. Casara, G. Sotti, P. Erba, et al. Preoperative Localization and Radioguided Parathyroid Surgery J. Nucl. Med., September 1, 2003; 44(9): 1443 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Olaizola, J. Zingraff, C. Heuguerot, L. Fajardo, A. Leger, J. Lopez, G. Acuna, A. Petraglia, A. Alvarez, H. Caorsi, et al. [99mTc]-Sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1201 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Neumann, C. B. Esselstyn Jr., A. Madera, C. O. Wong, and M. Lieber Parathyroid Detection in Secondary Hyperparathyroidism with 123I/99mTc-Sestamibi Subtraction Single Photon Emission Computed Tomography J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3867 - 3871. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |